The biotechnology and ridesharing industries have had divergent fortunes over the course of the COVID-19 pandemic. With Pfizer, Moderna, and Uber set to release Q1 2022 results in the coming days, it remains to be seen whether these trends will continue.
This week, Q4 earnings season is set to continue, with Booking, Home Depot, and Moderna expected to release their final reports for 2021. These earnings reports could reflect how various sectors of the economy fare over the final three months of last year.
News of the spreading COVID-19 Omicron variant has been rattling financial markets across the world this week. As indices drop and then pick back up with the headlines, investors may be wondering how major biotechnology firms plan to respond to this latest health crisis.